Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Scheibner

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Deutsche Medizinische Wochenschrift (1946)|January 3, 1986
[Brucella canis infection in man]J Schoenemann, R Lütticken, E Scheibner
Progress in Clinical and Biological Research|January 1, 1987
Preclinical safety of biotechnology products intended for human use: government regulatory position in the Federal Republic of GermanyR Bass, E Scheibner, B Schnieders
Toxicology Letters|December 1, 1992
Current guidelines for the preclinical safety assessment of therapeutic proteinsR Bass, U Kleeberg, H Schröder, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Deutsche Medizinische Wochenschrift (1946)|January 3, 1986
[Brucella canis infection in man]J Schoenemann, R Lütticken, E Scheibner
Progress in Clinical and Biological Research|January 1, 1987
Preclinical safety of biotechnology products intended for human use: government regulatory position in the Federal Republic of GermanyR Bass, E Scheibner, B Schnieders
Toxicology Letters|December 1, 1992
Current guidelines for the preclinical safety assessment of therapeutic proteinsR Bass, U Kleeberg, H Schröder, et al.
Pageof 2